All Resources
App Note
Discover Lead Molecules Against Difficult Membrane Targets Inaccessible by Hybridoma Methods

Learn about how the Opto™ Plasma B Discovery workflow increases hit recovery for difficult membrane-bound targets and provides access to greater sequence diversity when compared to traditional hybridoma methods.

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this App Note we discuss:

Discover up to 10-fold more hits against soluble and cell membrane antigens in days not weeks.
Generate diverse lead panels by sampling >50-fold greater sequence diversity.
Increase campaign yield and efficiency to reduce costs by 20-fold.
A Deeper Look

More about this App Note

Discover Lead Molecules Against Difficult Membrane Targets

In this application note, we demonstrate how the Opto Plasma B Discovery workflow increases hit recovery for a difficult membrane-bound target and provides access to more than 50-fold greater sequence diversity than a hybridoma workflow. Download to learn more and review the case studies.

Get the App Note